Engineered Cell Therapies and Antibodies

Engineered Cell Therapies and Antibodies Submit Abstract Register Now
Synthetic biology will play an important role in advancing adoptive T cell therapy. Engineered receptors and genetic circuits can make cell-based therapies safer and more powerful. Cellular engineering and genome editing can further improve the T cell as a frame work for therapy.The adoptive transfer of genetically engineered T cells with cancer-targeting receptors has shown tremendous promise for eradicating tumors in clinical trials. This form of cellular immunotherapy presents a unique opportunity to incorporate advanced systems and synthetic biology approaches to create cancer therapeutics with Here novel functions.
 
Here are certain engineered cell therapy which are engineered .

  • Chimeric Antigen Receptor
  • Monoclonal Antibody
  • Adoptive Cell Transfer
  • Gene Therapy

Related Conference of Engineered Cell Therapies and Antibodies

November 16-17, 2026

19th International Conference on Human Genomics and Genomic Medicine

Tokyo, Japan
December 01-02, 2026

Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

Dubai, UAE
February 18-19, 2027

22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

Singapore City, Singapore
March 11-12, 2027

17th International Conference on Human Genetics and Genetic Diseases

Berlin, Germany
March 11-12, 2027

20th International Conference on Genomics & Pharmacogenomics

Berlin, Germany
March 18-19, 2027

20th World Congress on Stem Cell Research

Paris, France
June 24-25, 2027

23rd Global Summit on Stem Cell & Regenerative Medicine

Paris, France
July 15-16, 2027

4th International Conference on Cell Science and Molecular Biology

London, UK

Engineered Cell Therapies and Antibodies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in